Pfizer Expects To Seek US Approval For COVID-19 Vaccine For Children Aged 6 Months To 5 Years In November
September 15, 2021 at 05:17 AM EDT
Pfizer Inc expects to apply for U.S. authorization of its COVID-19 vaccine for children aged six months and five years in November, the Financial Times reported.
